Mack Gene - Insider Non-Derivative Transactions at Gain Therapeutics, Inc. (GANX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 9, 2024, Mack Gene's relationship to Gain Therapeutics, Inc. (GANX) is Officer (CFO and Interim CEO), and currently has 14,400 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other GANX insiders.
Data Source: SEC.
Mack Gene - Insider Non-Derivative Transactions at GANX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 10, 2024 | P -- (Common Stock) | 14400 | 1.01 | 14400 |